Orange Book product · Brand (NDA)
SUCCINYLCHOLINE CHLORIDE
SUCCINYLCHOLINE CHLORIDE
At a glance
Aug 20, 2021
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 20, 2021
4 yr 11 mo ago
Today
Patent 12295932 expires
Listed drug product patent expiration.
Nov 02, 2041
in 15 yr 7 mo
Pharmaceutical detail
Active ingredient
SUCCINYLCHOLINE CHLORIDE
Strength
100MG/5ML (20MG/ML)
Dosage form
SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
TE code
Not listed
Application
NDA 215143
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —ANECTINEBrand (NDA)
NDA 008453 · SANDOZ
- —QUELICINBrand (NDA)
NDA 008845 · HOSPIRA
- —SUCOSTRINBrand (NDA)
NDA 008847 · APOTHECON
- 2025SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 217885 · FRESENIUS KABI USA
- 2025SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 217884 · FRESENIUS KABI USA
- 2024SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 218878 · BAXTER HLTHCARE CORP
- 2024SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 217873 · STERISCIENCE
- 2024SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 218467 · DR REDDYS
- 2023SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 217808 · EUGIA PHARMA
- 2023SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 216127 · MANKIND PHARMA
- 2022SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 216003 · BE PHARMS
- 2021SUCCINYLCHOLINE CHLORIDEGeneric (ANDA)
ANDA 214514 · MEITHEAL
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12295932 | Nov 02, 2041 | in 15 yr 7 mo | Product |

